Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C22H28FO8P.2Na |
Molecular Weight | 516.4046 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 8 / 8 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Na+].[Na+].[H][C@@]12C[C@@H](C)[C@](O)(C(=O)COP([O-])([O-])=O)[C@@]1(C)C[C@H](O)[C@@]3(F)[C@@]2([H])CCC4=CC(=O)C=C[C@]34C
InChI
InChIKey=PLCQGRYPOISRTQ-FCJDYXGNSA-L
InChI=1S/C22H30FO8P.2Na/c1-12-8-16-15-5-4-13-9-14(24)6-7-19(13,2)21(15,23)17(25)10-20(16,3)22(12,27)18(26)11-31-32(28,29)30;;/h6-7,9,12,15-17,25,27H,4-5,8,10-11H2,1-3H3,(H2,28,29,30);;/q;2*+1/p-2/t12-,15+,16+,17+,19+,20+,21+,22+;;/m1../s1
Molecular Formula | Na |
Molecular Weight | 22.9898 |
Charge | 1 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C22H28FO8P |
Molecular Weight | 470.4251 |
Charge | -2 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 8 / 8 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:35:21 UTC 2023
by
admin
on
Fri Dec 15 15:35:21 UTC 2023
|
Record UNII |
AI9376Y64P
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
373212
Created by
admin on Fri Dec 15 15:35:22 UTC 2023 , Edited by admin on Fri Dec 15 15:35:22 UTC 2023
|
||
|
NCI_THESAURUS |
C521
Created by
admin on Fri Dec 15 15:35:22 UTC 2023 , Edited by admin on Fri Dec 15 15:35:22 UTC 2023
|
||
|
EU-Orphan Drug |
EU/3/13/1158
Created by
admin on Fri Dec 15 15:35:22 UTC 2023 , Edited by admin on Fri Dec 15 15:35:22 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
16961
Created by
admin on Fri Dec 15 15:35:22 UTC 2023 , Edited by admin on Fri Dec 15 15:35:22 UTC 2023
|
PRIMARY | |||
|
41879
Created by
admin on Fri Dec 15 15:35:22 UTC 2023 , Edited by admin on Fri Dec 15 15:35:22 UTC 2023
|
PRIMARY | |||
|
48933
Created by
admin on Fri Dec 15 15:35:22 UTC 2023 , Edited by admin on Fri Dec 15 15:35:22 UTC 2023
|
PRIMARY | RxNorm | ||
|
4462
Created by
admin on Fri Dec 15 15:35:22 UTC 2023 , Edited by admin on Fri Dec 15 15:35:22 UTC 2023
|
PRIMARY | |||
|
1177032
Created by
admin on Fri Dec 15 15:35:22 UTC 2023 , Edited by admin on Fri Dec 15 15:35:22 UTC 2023
|
PRIMARY | |||
|
756722
Created by
admin on Fri Dec 15 15:35:22 UTC 2023 , Edited by admin on Fri Dec 15 15:35:22 UTC 2023
|
PRIMARY | |||
|
219-243-0
Created by
admin on Fri Dec 15 15:35:22 UTC 2023 , Edited by admin on Fri Dec 15 15:35:22 UTC 2023
|
PRIMARY | |||
|
100000090542
Created by
admin on Fri Dec 15 15:35:22 UTC 2023 , Edited by admin on Fri Dec 15 15:35:22 UTC 2023
|
PRIMARY | |||
|
CHEMBL1201302
Created by
admin on Fri Dec 15 15:35:22 UTC 2023 , Edited by admin on Fri Dec 15 15:35:22 UTC 2023
|
PRIMARY | |||
|
C1362
Created by
admin on Fri Dec 15 15:35:22 UTC 2023 , Edited by admin on Fri Dec 15 15:35:22 UTC 2023
|
PRIMARY | |||
|
AI9376Y64P
Created by
admin on Fri Dec 15 15:35:22 UTC 2023 , Edited by admin on Fri Dec 15 15:35:22 UTC 2023
|
PRIMARY | |||
|
DBSALT000843
Created by
admin on Fri Dec 15 15:35:22 UTC 2023 , Edited by admin on Fri Dec 15 15:35:22 UTC 2023
|
PRIMARY | |||
|
2392-39-4
Created by
admin on Fri Dec 15 15:35:22 UTC 2023 , Edited by admin on Fri Dec 15 15:35:22 UTC 2023
|
PRIMARY | |||
|
m4215
Created by
admin on Fri Dec 15 15:35:22 UTC 2023 , Edited by admin on Fri Dec 15 15:35:22 UTC 2023
|
PRIMARY | Merck Index | ||
|
SUB01615MIG
Created by
admin on Fri Dec 15 15:35:22 UTC 2023 , Edited by admin on Fri Dec 15 15:35:22 UTC 2023
|
PRIMARY | |||
|
AI9376Y64P
Created by
admin on Fri Dec 15 15:35:22 UTC 2023 , Edited by admin on Fri Dec 15 15:35:22 UTC 2023
|
PRIMARY | |||
|
SUB122698
Created by
admin on Fri Dec 15 15:35:22 UTC 2023 , Edited by admin on Fri Dec 15 15:35:22 UTC 2023
|
ALTERNATIVE | |||
|
DEXAMETHASONE SODIUM PHOSPHATE
Created by
admin on Fri Dec 15 15:35:22 UTC 2023 , Edited by admin on Fri Dec 15 15:35:22 UTC 2023
|
PRIMARY | Description: A white or almost white, crystalline powder.Solubility: Freely soluble in water; slightly soluble in ethanol (~750 g/L) TS; practically insoluble in dichloromethane R.Category: Adrenal hormone.Storage: Dexamethasone sodium phosphate should be kept in a tightly closed container, protected from light.Additional information: Dexamethasone sodium phosphate is very hygroscopic. Even in the absence of light it is graduallydegraded on exposure to a humid atmosphere, the decomposition being faster at higher temperatures. Dexamethasone sodiumphosphate may exhibit polymorphism. | ||
|
DTXSID3047429
Created by
admin on Fri Dec 15 15:35:22 UTC 2023 , Edited by admin on Fri Dec 15 15:35:22 UTC 2023
|
PRIMARY | |||
|
C004180
Created by
admin on Fri Dec 15 15:35:22 UTC 2023 , Edited by admin on Fri Dec 15 15:35:22 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (GC)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
correction factor: for the calculation of content, multiply the peak area of impurity A by 0.75
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |